Dr.Macs Bio-Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-12-2024
- Paid Up Capital ₹ 0.10 M
as on 25-12-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.00 M
as on 25-12-2024
- Revenue -89.92%
(FY 2020)
- Profit -78.61%
(FY 2020)
- Ebitda -95.77%
(FY 2020)
- Net Worth 4.91%
(FY 2020)
- Total Assets 6.19%
(FY 2020)
About Dr.Macs Bio-Pharma
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Murugulla Adharvanachari and Shobha Murugulla serve as directors at the Company.
- CIN/LLPIN
U24132TG2010PTC069173
- Company No.
069173
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2010
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Dr.Macs Bio-Pharma Private Limited offer?
Dr.Macs Bio-Pharma Private Limited offers a wide range of products and services, including Floor Cleaner, Liquid Cleaner, API Intermediate.
Who are the key members and board of directors at Dr.Macs Bio-Pharma?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Murugulla Adharvanachari | Director | 28-Jun-2010 | Current |
Shobha Murugulla | Director | 28-Jun-2010 | Current |
Financial Performance of Dr.Macs Bio-Pharma.
Dr.Macs Bio-Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 89.92% decrease. The company also saw a substantial fall in profitability, with a 78.61% decrease in profit. The company's net worth moved up by a moderate rise of 4.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Macs Bio-Pharma?
In 2019, Dr.Macs Bio-Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
City Union Bank Limited Creation Date: 01 Mar 2016 | ₹2.00 M | Open |
How Many Employees Work at Dr.Macs Bio-Pharma?
Unlock and access historical data on people associated with Dr.Macs Bio-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Macs Bio-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Macs Bio-Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.